Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001395 |
---|---|
Receipt number | R000001696 |
Scientific Title | Phase I clinical study of Glypican-3 peptide vaccine in patients with advanced Hepatocellular carcinoma |
Date of disclosure of the study information | 2008/09/26 |
Last modified on | 2013/05/10 15:13:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/09/26 13:47:36 | ||
2 | Update | 2009/03/27 18:57:55 | Recruitment status Last follow-up date |
|
3 | Update | 2009/03/27 19:12:37 | Target sample size |
|
4 | Update | 2009/09/26 11:40:12 | Recruitment status Last follow-up date |
|
5 | Update | 2009/09/26 11:47:24 | Target sample size |
|
6 | Update | 2009/10/14 16:08:31 | Recruitment status |
|
7 | Update | 2010/09/30 00:10:36 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2013/05/10 15:13:42 | Publication of results |